About Precision Epigenomics
Precision Epigenomics is a private company based in Tucson, Arizona, incorporated in 2021 in Delaware. It has reported $1,382,795 raised in two offerings on Form D since April 2024. Its chief executive is Mark Nelson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2025 | Sep 23, 2025 | $265,000of $2.0M target | 5 | $53,000 | DebtRule 506(b) | Form D ↗ |
| Mar 18, 2024 | Apr 1, 2024 | $1,117,795of $1.7M target | 2 | $558K | EquityRule 506(c) | Form D ↗ |
| Total, two offerings | $1,382,795 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Precision Epigenomics's Form D filed Sep 23, 2025.
LS
Lisa Shaffer
Director
MN
Mark Nelson
Chief Executive Officer and director
LL
Lisa Jensen-Long
Executive officer
BF
Barnard Futscher
Executive officer
MM
Matthew Miller
Executive officer
RB
Richard Bernert
Executive officer and director
MW
Marie Wesselhoft
Director
Earlier filings also listed Bernard Futscher (executive officer, last listed Apr 2024).